{"slideshow_credits": null, "snippet": "The drug, canagliflozin, is being developed by Johnson & Johnson and is part of a group of drugs that lowers blood sugar by causing the sugar to be excreted through urine.", "abstract": "Food and Drug Administration advisory panel votes 10 to 5 to approve diabetes drug canagliflozin, which could be the first in a new class of drugs in the United States to treat the disease; some members raise concerns about several risks associated with drug, made by Johnson & Johnson.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/01/11/business/fda-advisory-panel-votes-to-approve-diabetes-drug.html", "lead_paragraph": "The drug, canagliflozin, is being developed by Johnson & Johnson and is part of a group of drugs that lowers blood sugar by causing the sugar to be excreted through urine.", "headline": {"seo": "F.D.A. Advisory Panel Votes to Approve Diabetes Drug", "main": "F.D.A. Advisory Panel Votes to Approve Diabetes Drug", "print_headline": "F.D.A. Advisory Panel Votes to Approve Diabetes Drug"}, "_id": "50ef7b7000315214fbb8397e", "word_count": "673", "multimedia": [], "pub_date": "2013-01-11T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Diabetes", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "3"}, {"value": "Johnson & Johnson", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "Janssen Pharmaceutica", "name": "organizations", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}